OOIR: Observatory of International Research

Papers

(The TQCC of Menopause-The Journal of the North American Menopause Society is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
The effect of probiotic administration on the severity of menopausal symptoms and mental health of postmenopausal women: a triple-blind randomized controlled trial in the West of Iran	487
Reflecting on the enduring effects of childhood maltreatment	130
Validation of the Menopause Transition Scale (MTS)	54
Risk factors for delayed intrauterine device removal among menopausal women in rural China	31
Psychometric properties and validity of the Menopause Rating Scale in postmenopausal Portuguese women	27
#Menopause: the menopause ontology project	21
Urban-rural differences in epidemiology and risk factors of menopause syndrome in middle-aged Chinese women	21
A call for health equity when addressing menopausal symptoms	20
Vitamin D supplements and prevalent overactive bladder in women from midlife through older ages	19
Dietary patterns and prevalence of multimorbidity in women in southern Brazil	18
Treating where it hurts: tailoring the genitourinary syndrome of menopause treatments	18
Health screening of middle-aged women: what factors impact longevity?	16
Risk factors for future osteoporosis in perimenopausal Japanese women	16
Efficacy, tolerability, and endometrial safety of ospemifene compared with current therapies for the treatment of vulvovaginal atrophy: a systematic literature review and network meta-analysis	16
Perimenopause meets life: observations from the Women Living Better Survey	16
Low-serum anti-Müllerian hormone in middle-aged women associates with obesity markers	15
Superficial dyspareunia treatment with hyperstacking of erbium:yttrium-aluminum-garnet SMOOTH laser: a short-term, pilot study in breast cancer survivors	14
The prevalence of osteoporosis in postmenopausal women in urban Tianjin, China and its related factors	13
The association of vasomotor symptoms during the menopausal transition and cognition in later life	13
The association between hormone therapy and the risk of lung cancer in postmenopausal women: a 16-year nationwide population-based study	13
Association between vitamin D and calcium intakes, breast microcalcifications, breast tissue age-related lobular involution and breast density	13
Menopause hormone therapy and urinary symptoms: a systematic review	13
Lessons Learned in Clinical Research Recruitment of Midlife Latinas During COVID-19	13
Health care concerns in women at midlife: differences by race, ethnicity, and neighborhood socioeconomic status	12
Quality of life in Spanish postmenopausal breast cancer patients with localized disease who finish endocrine treatment: a prospective study	12

Examining long-term health impacts of multiparity	12
Association of parity with body mass index and cardiometabolic risk in high-parous women	11
Exercise training and vascular function in postmenopausal individuals: a systematic review and meta-analysis	11
Risk of high depressive symptoms after the final menstrual period: the Study of Women’s Health Across the Nation (SWAN)	10
Pharmacological interactions and menopausal hormone therapy: a review	10
Cytological characteristics of premalignant cervical epithelial lesions in postmenopausal women based on endocrine indices and parakeratosis	10
Psychometric evaluation of the German Day-to-Day Impact of Vaginal Aging questionnaire using data from two intervention studies	10
Impact of the CBT-Meno protocol on menopause-specific beliefs, dysfunctional attitudes, and coping behaviors	10
Perception of higher frequency of daily hot flashes in 50-year-old women today: a study of trends over time during 48 years in the Population Study of Women in Gothenburg, Sweden	9
Efficacy and safety of lemborexant in midlife women with insomnia disorder	9
Letters to the editor	9
Network analysis of eating disorder symptoms in women in perimenopause and early postmenopause	8
Menopause hormone therapy and sarcodynapenia: the Canadian Longitudinal Study on Aging	8
Nonhormone treatments for vasomotor symptoms	8
Postmenopausal giant ovarian tumor: a rare case report and literature review	8
Screening for factors at midlife associated with reduced longevity in women	8
Indian physicians' attitudes and practice regarding menopause and its management: a focus group discussion	8
Impact of vitamin D supplementation on modulating heat-shock proteins in postmenopausal women: a randomized, double-blind, placebo-controlled study	7
Lipoprotein subfractions and subclinical vascular health in middle aged women: does menopause status matter?	7
Gonadotropin-releasing hormone agonists for ovarian protection during breast cancer chemotherapy: a systematic review and meta-analysis	7
Prasterone in the treatment of mild to moderate urge incontinence: an observational study	7
Climacteric status is associated with sexual dysfunction at the age of 46 years: a population-based study	7
Hormone therapy for sexual function in perimenopausal and postmenopausal women: a systematic review and meta-analysis update	7
Menopausal hormone therapy and the risk of type 2 diabetes mellitus: Health Insurance Database in South Korea–based retrospective cohort study	7
Menopause for justice-involved women: consequences and care in prison systems	7
Menopause: The Journal of The North American Menopause Society Volume 29, 2022	7
Isolated vitamin D supplementation improves the adipokine profile of postmenopausal women: a randomized clinical trial	7
Genitourinary syndrome of menopause—I know it when I see it—or do I?	7
Hysterectomy with or without ovarian conservation: similar associations with vascular health?	7
Update on estrogen therapy and prevention of bone loss	6
Trends in osteoporosis medication use in US postmenopausal women: analysis of the National Health and Nutrition Examination Survey 1999-2000 through 2017-2018	6
Should vitamin D supplements be prescribed routinely for midlife women?	6
Practice patterns and perspectives regarding treatment for symptoms of menopause: qualitative interviews with US health care providers	6
Prophylactic salpingectomy with delayed oophorectomy as a two-staged alternative for primary prevention of ovarian cancer in BRCA1/2 mutation carriers: women's point of view	6
Composite dietary antioxidant intake and osteoporosis likelihood in premenopausal and postmenopausal women: a population-based study in the United States	6
Psychometric properties of a Persian version of the Vulvovaginal Symptoms Questionnaire for measuring vulvovaginal symptoms in postmenopausal women	6
2022 Annual Meeting of The North American Menopause Society October 12 – 15, 2022, Atlanta, GA	6
Uterine arcuate artery calcification as a potential marker of cardiovascular risk—a preliminary study	6
Inflamm-aging or inflamm-opause: is inflammation the cause or consequence of vasomotor symptoms?	6
Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1)	6
Interactions between nutrient intake and comorbidities for quality of life in premenopausal and postmenopausal women	6